HEMACARE CORPORATION Profile
ABOUT US
HemaCare, a Charles River company, is a global leader in the supply and customization of human-derived biological products and services for biomedical research, drug discovery, and cellular therapy process development. Through our network of collection centers with access to an extensive recallable and reliable donor network, we provide clients with the cellular material they need for the development of the next generation of cell and gene therapies – including RUO and GMP fresh and cryopreserved starting material and isolated cellular material derived from peripheral blood (normal and mobilized), bone marrow, and cord blood. Combined with Charles River’s integrated, early-stage portfolio of discovery, safety assessment, and manufacturing support services, we provide customers comprehensive solutions from discovery through commercialization.
The HemaCare Advantage
Whether your company is a small start-up or a fortune 500 pharmaceutical giant, consistent, reliable, customizable starting material is essential to your success. High-quality human primary cells are the foundation for any experiment and can significantly impact downstream applications. With services available globally, HemaCare is the leading provider of high-quality human cellular material.
- State-of-the-art Facility
- Apheresis Collection Expertise
- GMP Biologics and Services
- Largest Pedigreed Donor Pool with Diverse Backgrounds
- Customized Cells
- Highest Quality Control Standards